LBG
GILD icon

Lloyds Banking Group’s Gilead Sciences GILD Stock Holding History

Lloyds Banking Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,910
Closed -$144K – 70
2018
Q1 		$144K Buy
1,910
+105
+6% +$8.35K 1.11% 38
2017
Q4 		$129K Hold
1,805
– – 1.2% 38
2017
Q3 		$146K Sell
1,805
-161
-8% -$12.3K 1.46% 29
2017
Q2 		$139K Sell
1,966
-41
-2% -$2.73K 1.35% 35
2017
Q1 		$136K Sell
2,007
-210
-9% -$14.8K 1.23% 39
2016
Q4 		$158K Sell
2,217
-96
-4% -$7.14K 1.37% 36
2016
Q3 		$183K Sell
2,313
-67
-3% -$5.44K 1.64% 34
2016
Q2 		$198K Hold
2,380
– – 1.63% 33
2016
Q1 		$218K Buy
+2,380
New +$215K 1.78% 27
2014
Q4 		– Sell
-25,626
Closed -$2.73M – 196
2014
Q3 		$2.73M Buy
25,626
+3,940
+18% +$386K 0.74% 27
2014
Q2 		$1.8M Sell
21,686
-1,064,968
-98% -$82.9M 0.43% 65
2014
Q1 		$77M Buy
1,086,654
+231,579
+27% +$18.2M 0.69% 34
2013
Q4 		$64.3M Buy
855,075
+59,077
+7% +$4.11M 0.58% 49
2013
Q3 		$50M Buy
795,998
+200,475
+34% +$12M 0.51% 56
2013
Q2 		$30.5M Buy
+595,523
New +$31M 0.32% 82

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lloyds Banking Group's GILD Position: Q2 2018 in Review

Lloyds Banking Group sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 1,910 shares — an estimated $144K sold.

Lloyds Banking Group first reported a position in GILD in Q2 2013 and held it in 15 quarters. The position peaked at $77M in Q1 2014. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Lloyds Banking Group reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Lloyds Banking Group sold 1,910 Gilead Sciences shares in Q2 2018, an estimated $144K.
  • Lloyds Banking Group first reported a position in Gilead Sciences in Q2 2013 and held it in 15 quarters.
  • Lloyds Banking Group's Gilead Sciences position peaked at $77M in Q1 2014.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Lloyds Banking Group's 13F filing for Q2 2018, filed 8 Aug 2018.